Coronavirus vaccine in China produces neutralizing antibodies in early-stage trial

by CNBC • New

A potential coronavirus vaccine developed in China appeared to provoke neutralizing antibodies in dozens of patients in an early-stage clinical trial, an important step in developing a vaccine that might provide immunity to Covid-19.

Read More on CNBC

Keep exploring with these related links:

Discover Stocks with SpeculatingStocks

Join the Social Network for Investors

Social & Financial Data on Stocks

Stock Comparison Tool


Stock Picks

Discuss Any Cryptocurrency

'Buy' Sentiment Data for Symbols

'Sell' Sentiment Data for Symbols